Cargando…
Extracorporeal photochemotherapy induces bona fide immunogenic cell death
Extracorporeal photochemotherapy (ECP) is employed for the management of cutaneous T cell lymphoma (CTCL). ECP involves the extracorporeal exposure of white blood cells (WBCs) to a photosensitizer, 8-methoxypsoralen (8-MOP), in the context of ultraviolet A (UVA) radiation, followed by WBC reinfusion...
Autores principales: | Tatsuno, Kazuki, Yamazaki, Takahiro, Hanlon, Douglas, Han, Patrick, Robinson, Eve, Sobolev, Olga, Yurter, Alp, Rivera-Molina, Felix, Arshad, Najla, Edelson, Richard L., Galluzzi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675789/ https://www.ncbi.nlm.nih.gov/pubmed/31371700 http://dx.doi.org/10.1038/s41419-019-1819-3 |
Ejemplares similares
-
Extracorporeal Photochemotherapy: Mechanistic Insights Driving Recent Advances and Future Directions
por: Wei, Brian M., et al.
Publicado: (2020) -
The Bona Fide Nurse
Publicado: (1919) -
A bona fide MAP kinase
por: Oldach, Laurel
Publicado: (2022) -
Chromomycin A(5) induces bona fide immunogenic cell death in melanoma
por: Florêncio, Katharine Gurgel Dias, et al.
Publicado: (2022) -
What Are the bona fide GSK3 Substrates?
por: Sutherland, Calum
Publicado: (2011)